GENE ONLINE|News &
Opinion
Blog

Reed Slater

WRITTEN BY Reed Slater

Spectrum to Cut 75% of Staff and NSCLC Program Following CLR
2022-11-28
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
Hemgenix Marks Most Expensive Treatment Ever and First Gene Therapy for Hemophilia B
2022-11-22
BioFuture NYC 2022: Using Technology to Prepare for an Aging Population
2022-11-22
Provention’s Tzield Snags FDA’s Approval to Slow Type 1 Diabetes Progression
2022-11-20
Regeneron Pays CytomX $2 Billion Biobucks to Develop Bispecific Cancer Therapies Together
2022-11-17
Kriya Scoops Up Redpin to Break into Neurology Gene Therapies
2022-11-16
Walmart To Settle Opioid Lawsuits with $3.1 Billion, U.S. Government Mulls OTC Naloxone
2022-11-15
Sanofi, GSK Secure European COVID-19 Booster Approval, AstraZeneca Withdraws U.S. Application
2022-11-10
Insilico Makes its Biggest AI Deal Ever with Sanofi for Potential $1.2 Billion
2022-11-09
Supreme Court Rejects Juno, Welcomes Amgen Back to Patent Discussions
2022-11-08
Eli Lilly and BI Notch Clinical Win for Kidney Disease Drug
2022-11-07
CDC Unveils Updated Set of Opioid Prescription Guidelines
2022-11-04
Alkermes to Break Oncology Sector into Independent Company
2022-11-03
Janssen Drops Out of Prostate Cancer Clinical Trial Due to Lack of Patients
2022-11-01
1 3 4 5 6 7 15
Scroll to Top